Recurring Limited Submissions

Slots: 1.

Deadlines

Internal Deadline: Contact RII.

Nominations Due: February 22, 2023, 5pm ET/2pm PT

External Deadline: May 3, 2023, 5pm ET

Award Information

Award Type: Grant

Anticipated Award Amount: Each applicant can receive from FFAR up to $150,000 per year for a maximum of three years totaling $450,000 investment. Indirect costs are limited to 10% of the total award, including subcontracts, if applicable. Unrecovered indirect cost is not permitted. Construction and renovation costs are not allowed. Salaries of principal investigators are allowed for time not covered by institutional or other grant funds and effort should be commensurate with the research proposed.

Who May Serve as PI: We give preference to individuals who are within eight years of receiving a Ph.D. or equivalent degree. Eligible candidates must also conduct research that aligns with our Challenge Areas.

Link to Award: https://foundationfar.org/grants-funding/opportunities/new-innovators-request-for-applications/

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

• (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
• (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The New Innovator in Food & Agriculture Research Award provides early-career scientists the investment needed to propel them into successful research careers.

Young faculty in the sciences often struggle to secure grant funding. We established the New Innovator Awards to launch the careers of promising scientists whose research addresses significant food and agriculture challenges. These awards allow the grantees to focus exclusively on research without the pressure of securing additional funding.

We grant New Innovator Awards to outstanding early career investigators who have been in the tenure-track position no longer than three years. The Award goes to individuals with the creative ideas, skills, knowledge and resources necessary to carry out the proposed research program.

Individuals with significant research experience prior to obtaining their faculty position are not eligible for this award.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Slots: 2.

Deadlines

Internal Deadline: February 17, 2023, 5pm PT

LOI: March 31, 2023 (one-page Letter of Intent and CV emailed to researchgrants@breastcanceralliance.org)

External Deadline: July 21, 2023, on or before midnight EDT

Award Information

Award Type: Grant

Anticipated Award Amount: This is a two-year grant for a total of $125,000, with half the grant award being paid out each year. Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs. 

Who May Serve as PI: Applicants for the 2024 award must (i) not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2024; (ii) not have been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects.

Link to Award: https://breastcanceralliance.org/how-to-apply (middle of page)

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

• (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
• (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions throughout the contiguous United States.

The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.

To accomplish this, the Breast Cancer Alliance:

• Funds a diversified portfolio of breast cancer research
• Funds Breast Surgery Fellowship programs
• Funds the purchase of equipment for research
• Provides timely information on breast health and the importance of early detection
• Supports outreach and case managerial services, education, counseling, and mammograms for underserved and underinsured women in mid to southern Connecticut and Westchester County, New York

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Slots: 2

Deadlines

Internal Deadline: Friday, February 17, 2023, 5pm PT

LOI: March 31, 2023 – one-page Letter of Intent and CV due to researchgrants@breastcanceralliance.org.

External Deadline: July 21, 2023, midnight EDT

Award Information

Award Type: Grant

Anticipated Award Amount: 1 year grant for $100,000. Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs.

Who May Serve as PI: Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. 

Link to Award: https://breastcanceralliance.org/how-to-apply (top of the page)

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

• (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
• (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.

To accomplish this, Breast Cancer Alliance:

• Funds a diversified portfolio of breast cancer research
• Funds Breast Surgery Fellowship programs
• Funds the purchase of equipment for research
• Provides timely information on breast health and the importance of early detection
• Supports outreach and case managerial services, education, counseling and mammograms for underserved and underinsured women in mid to southern Connecticut and Westchester County, New York

To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists, including post-docs, whose primary focus is breast cancer research and who are at any stage of their careers, to apply for funding for the Exceptional Project Grant. This grant is open to applicants at institutions within the United States.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Slots: 1 Early-Career Scientist and 1 Senior Scientist.

Deadlines

Internal Deadline: Friday, February 17, 2023, 5pm PT

Nomination Deadline: Friday, March 31, 2023, 11:59pm ET

Letter of Support Deadline: Friday, April 14, 2023, 11:59pm ET (Letters of Support Due)

Award Information

Award Type: Grant

Anticipated Award Amount: $200,000

Who May Serve as PI: 

Early-Career Scientist

The nominee must:

• Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
• Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
• Currently hold a junior level Post-doctoral or Faculty position at an invited academic, government, or non-profit institution or equivalent.
• Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with their current institution’s policies) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe. Instructions regarding how to request an extension are provided at the end of the Guidelines section.

Senior Scientist

The nominee must:

• Have been engaged in active research for a length of time of more than 10 years since gaining their doctorate degree or equivalent.
• Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
• Currently hold a senior level Faculty position at an invited academic, government, or non-profit institution or equivalent.
• Have made multiple, extensive, and impactful research contributions to advance the Award field.

Link to Award: https://www.nyas.org/awards/innovators-in-science-award/

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

• (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
• (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

Established in 2016, the Innovators in Science Award is administered by the New York Academy of Sciences and sponsored by Takeda. This global award recognizes a promising Early-Career Scientist’s and an outstanding Senior Scientist’s contributions to biomedical science and is intended to support their commitment to innovative research. Select international institutions are invited to submit nominations. Each winner receives an unrestricted prize of US$200,000 for their excellence in, and commitment to, innovative science that has significantly advanced a rotating focus area. 

The 2024 Innovators in Science Award will recognize achievements in Cancer Immunology. Cancer remains the second-leading cause of death worldwide, and the global burden is expected to rise as the population grows and ages.¹ Despite major advances in the drug development pipeline, about only 11% of new cancer therapeutics make it into the clinic.² This Award recognizes bold, creative scientists seeking to increase our molecular and immunological understanding of cancer and inform novel therapeutic approaches.

Review Criteria:

Early-Career Scientist

• Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
• Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
• Novelty: The extent to which the work challenges existing paradigms, employs innovative new methodologies or concepts, and/or pursues an original question.
• Promise: The extent to which the nominee has made innovative research contributions and shows exceptional promise for significant future achievement in the Award field.

Senior Scientist

• Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
• Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
• Novelty: The extent to which the work challenges existing paradigms, employs new innovative methodologies or concepts, and/or pursues an original question.
• Promise: The extent to which the nominee has made impactful research contributions and future prospects for further significant contributions in the Award field.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Slots: As per Agilent: “We invite many top universities to nominate one candidate. Of course, if your university is so fortunate as to have two world-leading early career professors in the area of this call, please do nominate both.”

Deadlines

Internal Deadline: Contact RII.

LOI: N/A

External Deadline: February 24, 2023 to university_relations@agilent.com

Award Information

Award Type: Grant

Anticipated Award Amount: An unrestricted research award of $120,000 to be distributed in 2 years to university in the professor’s name. (Option to use all or part of award to obtain Agilent products at 50% discount; option to accelerate payments to facilitate procurement of equipment with list price over $120,000).

Who May Serve as PI: 

• Professor must hold a tenure-tracked faculty position
• Must have completed Ph.D. or M.D. residency within 12 years of award year
  (additional extensions may apply, please see FAQ)

Link to Award: https://www.agilent.com/univ_relation/profaward/index.shtml

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

• (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
• (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The purpose of the Agilent Early Career Professor Award is to:

• Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
• Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
• Build the prominence of Agilent as a sponsor of university research

Selection Criteria

• Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
• Outstanding potential for future research
• Professor completed Ph.D. (residency in case of M.D.’s or M.D. Ph.D’s) not earlier than January 2012. See FAQ
• Alignment with the 2022 Focus: Contributions to the development of live cell analytical tools to identify and measure novel critical quality attributes (CQA) to advance biomanufacturing applications.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.